Proteomics identifies EGF‐like domain multiple 7 as a potential therapeutic target for epidermal growth factor receptor‐positive glioma

Proteomics identifies EGF‐like domain multiple 7 as a potential therapeutic target for epidermal growth factor receptor‐positive glioma

Abstract Background Glioma, the most frequent primary tumor of the central nervous system, has poor prognosis. The epidermal growth factor receptor (EGFR) pathway and angiogenesis play important roles in glioma growth, invasion, and recurrence. The present study aimed to use proteomic methods to pro...

Full description

Bibliographic Details
Main Authors: Fei‐yi‐fan Wang, Si‐yi Wang‐gou, Hang Cao, Nian Jiang, Qi Yang, Qi Huang, Chun‐hai Huang, Xue‐jun Li
Format: Article
Language:English
Published: Wiley 2020-10-01
Series:Cancer Communications
Subjects:
Glioma
Proteomics
Epidermal growth factor receptor
EGF‐like domain multiple 7
Targeted therapy
Selumetinib
Online Access:https://doi.org/10.1002/cac2.12092

Internet

https://doi.org/10.1002/cac2.12092

Similar Items